Full Name
YAP CHUN WEI
(not current staff)
Variants
Yap, C.W.
Wei, Y.C.
Chun, W.Y.
Yap, C.-W.
 
Main Affiliation
 
 
Email
phayapc@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Author:  Yap, C.-W.
Department:  PHARMACY AND PHARMACEUTICAL SCIENCES

Results 1-14 of 14 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-May-20123D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA)Ma, X. ; Xiang, G.; Yap, C.-W. ; Chui, W.-K. 
21-Aug-2012A clinical decision support tool to predict survival in cancer patients beyond 120 days after palliative chemotherapyNg, T.; Chew, L. ; Yap, C.W. 
321-May-2013An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs)Prakash, B.D.; Esuvaranathan, K.; Ho, P.C. ; Pasikanti, K.K.; Yong Chan, E.C. ; Yap, C.W. 
4Aug-2012An investigation of the bioactivation potential and metabolism profile of zebrafish versus humanChng, H.T.; Ho, H.K. ; Yap, C.W. ; Lam, S.H. ; Chan, E.C.Y. 
51-Aug-2012Clinical and demographic predictors for vitamin D deficiency in multiethnic Asian patients with chronic kidney diseaseLoh, ZY; Yap, CW ; Vathsala, A ; How, P 
624-Dec-2010Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic dataKoh, Y.; Pasikanti, K.K.; Yap, C.W. ; Chan, E.C.Y. 
7Jan-2012Identification of active compounds from medicinal plant extracts using gas chromatography-mass spectrometry and multivariate data analysisChing, J.; Soh, W.-L.; Tan, C.-H.; Lee, J.-F.; Tan, J.-Y.C.; Yang, J.; Yap, C.-W. ; Koh, H.-L. 
810-Oct-2013Identification of michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activityGan, F.-F. ; Kaminska, K.K.; Yang, H.; Liew, C.-Y.; Leow, P.-C.; So, C.-L.; Tu, L.N.L.; Roy, A.; Yap, C.-W. ; Kang, T.-S. ; Chui, W.-K. ; Chew, E.-H. 
9Jul-2012Interaction of lapatinib with cytochrome P450 3A5Chan, E.C.Y. ; New, L.S. ; Chua, T.B.; Yap, C.W. ; Ho, H.K. ; Nelson, S.D.
1015-Feb-2009Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometryChan, E.C.Y. ; Lee, S.N. ; Chun, W.Y. ; Lin, T.G.
1115-May-2011Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo- pyrimidines as potent human A3 adenosine receptor antagonistsCheong, S.L. ; Federico, S.; Venkatesan, G.; Paira, P. ; Shao, Y.-M.; Spalluto, G.; Yap, C.W. ; Pastorin, G. 
1228-Jul-2011Pilot study on developing a decision support tool for guiding re-administration of chemotherapeutic agent after a serious adverse drug reactionLoke, P.Y.; Chew, L. ; Yap, C.W. 
132015Predictors of anemia in a multi-ethnic chronic kidney disease population: a case?control studyLau, B.C.V; Ong, K.Y; Yap, C.W ; Vathsala, A ; How, P 
1415-Dec-2012Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer propertiesSaha, S.; Chan, D.S.Z.; Lee, C.Y.; Wong, W.; New, L.S. ; Chui, W.K. ; Yap, C.W. ; Chan, E.C.Y. ; Ho, H.K.